Logo image of AVCR.CA

AVRICORE HEALTH INC (AVCR.CA) Stock Fundamental Analysis

TSX-V:AVCR - TSX Venture Exchange - CA0545211090 - Common Stock - Currency: CAD

0.08  0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to AVCR. AVCR was compared to 8 industry peers in the Health Care Technology industry. While AVCR has a great health rating, there are worries on its profitability. AVCR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year AVCR has reported negative net income.
AVCR had a positive operating cash flow in the past year.
AVCR had negative earnings in each of the past 5 years.
In multiple years AVCR reported negative operating cash flow during the last 5 years.
AVCR.CA Yearly Net Income VS EBIT VS OCF VS FCFAVCR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M -2M -3M -4M

1.2 Ratios

AVCR has a Return On Assets of -42.76%. This is in the better half of the industry: AVCR outperforms 62.50% of its industry peers.
Looking at the Return On Equity, with a value of -46.86%, AVCR is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
ROA -42.76%
ROE -46.86%
ROIC N/A
ROA(3y)-29.53%
ROA(5y)-86.04%
ROE(3y)-36.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AVCR.CA Yearly ROA, ROE, ROICAVCR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

AVCR has a Gross Margin of 42.53%. This is in the better half of the industry: AVCR outperforms 62.50% of its industry peers.
In the last couple of years the Gross Margin of AVCR has declined.
The Profit Margin and Operating Margin are not available for AVCR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.52%
GM growth 5Y-2.21%
AVCR.CA Yearly Profit, Operating, Gross MarginsAVCR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K -25K

More info and screens

8

2. Health

2.1 Basic Checks

AVCR does not have a ROIC to compare to the WACC, probably because it is not profitable.
AVCR has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, AVCR has more shares outstanding
AVCR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AVCR.CA Yearly Shares OutstandingAVCR.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
AVCR.CA Yearly Total Debt VS Total AssetsAVCR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

2.2 Solvency

AVCR has an Altman-Z score of 11.82. This indicates that AVCR is financially healthy and has little risk of bankruptcy at the moment.
AVCR's Altman-Z score of 11.82 is amongst the best of the industry. AVCR outperforms 87.50% of its industry peers.
There is no outstanding debt for AVCR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 11.82
ROIC/WACCN/A
WACC8.82%
AVCR.CA Yearly LT Debt VS Equity VS FCFAVCR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M -2M 3M

2.3 Liquidity

A Current Ratio of 7.40 indicates that AVCR has no problem at all paying its short term obligations.
AVCR has a Current ratio of 7.40. This is amongst the best in the industry. AVCR outperforms 100.00% of its industry peers.
AVCR has a Quick Ratio of 7.38. This indicates that AVCR is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 7.38, AVCR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.4
Quick Ratio 7.38
AVCR.CA Yearly Current Assets VS Current LiabilitesAVCR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

More info and screens

3

3. Growth

3.1 Past

AVCR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -194.29%.
AVCR shows a small growth in Revenue. In the last year, the Revenue has grown by 2.89%.
Measured over the past years, AVCR shows a very strong growth in Revenue. The Revenue has been growing by 170.57% on average per year.
EPS 1Y (TTM)-194.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-147.06%
Revenue 1Y (TTM)2.89%
Revenue growth 3Y239.04%
Revenue growth 5Y170.57%
Sales Q2Q%-61.39%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AVCR.CA Yearly Revenue VS EstimatesAVCR.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AVCR. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AVCR.CA Price Earnings VS Forward Price EarningsAVCR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AVCR is valued cheaper than 100.00% of the companies in the same industry.
AVCR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AVCR is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.4
EV/EBITDA 24.54
AVCR.CA Per share dataAVCR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 0.02 0.03 0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AVCR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AVRICORE HEALTH INC

TSX-V:AVCR (8/1/2025, 7:00:00 PM)

0.08

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)05-28 2025-05-28
Earnings (Next)08-27 2025-08-27
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners10.17%
Ins Owner ChangeN/A
Market Cap8.10M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.98
P/FCF 13.4
P/OCF 10.03
P/B 4.15
P/tB 4.31
EV/EBITDA 24.54
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY7.46%
OCF(TTM)0.01
OCFY9.97%
SpS0.04
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -42.76%
ROE -46.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.53%
FCFM 14.76%
ROA(3y)-29.53%
ROA(5y)-86.04%
ROE(3y)-36.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.52%
GM growth 5Y-2.21%
F-Score6
Asset Turnover1.91
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 53.16%
Cap/Sales 4.97%
Interest Coverage N/A
Cash Conversion 290.93%
Profit Quality N/A
Current Ratio 7.4
Quick Ratio 7.38
Altman-Z 11.82
F-Score6
WACC8.82%
ROIC/WACCN/A
Cap/Depr(3y)316.46%
Cap/Depr(5y)N/A
Cap/Sales(3y)34.03%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-194.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-147.06%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.89%
Revenue growth 3Y239.04%
Revenue growth 5Y170.57%
Sales Q2Q%-61.39%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y69.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y138.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y638.6%
OCF growth 3YN/A
OCF growth 5YN/A